TY - JOUR
T1 - Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel
AU - Regev-Yochay, G.
AU - Carmeli, Y.
AU - Raz, M.
AU - Pinco, E.
AU - Etienne, J.
AU - Leavitt, A.
AU - Rubinstein, E.
AU - Navon-Venezia, S.
N1 - Funding Information:
Acknowledgments We thank the participating physicians from Hashfela District of Macabbi Healthcare Services (the IJAP Maccabi study group) for their cooperation and help in recruiting the study population. Guidelines for human experimentation in clinical research were followed. Financial support for this study was provided by the Chief Scientist Office, Israeli Ministry of Health and by Maccabi Healthcare Services.
PY - 2006/11
Y1 - 2006/11
N2 - The aims of the study presented here were to determine the prevalence of Staphylococcus aureus carriage and, specifically, community-acquired methicillin-resistant S. aureus (CA-MRSA) carriage in children and their parents in Israel and to determine the genetic relatedness of these isolates. S. aureus was isolated from 580 of 3,373 (17.2%) individuals screened. The predominant type identified by pulsed-field gel electrophoresis was strain ST45-MSSA (25%). Five MRSA isolates were detected, and two of these were classified as CA-MRSA, based on the following criteria: no previous contact with a healthcare facility, absence of a multidrug-resistant (MDR) phenotype, and presence of SCCmec type IV. Isolates were negative for pvl and were classified as ST-45-MRSA. Although CA-MRSA is still rare in Israel, the genetic relatedness of the strains found in this study to a successful MSSA clone warrants close follow up.
AB - The aims of the study presented here were to determine the prevalence of Staphylococcus aureus carriage and, specifically, community-acquired methicillin-resistant S. aureus (CA-MRSA) carriage in children and their parents in Israel and to determine the genetic relatedness of these isolates. S. aureus was isolated from 580 of 3,373 (17.2%) individuals screened. The predominant type identified by pulsed-field gel electrophoresis was strain ST45-MSSA (25%). Five MRSA isolates were detected, and two of these were classified as CA-MRSA, based on the following criteria: no previous contact with a healthcare facility, absence of a multidrug-resistant (MDR) phenotype, and presence of SCCmec type IV. Isolates were negative for pvl and were classified as ST-45-MRSA. Although CA-MRSA is still rare in Israel, the genetic relatedness of the strains found in this study to a successful MSSA clone warrants close follow up.
UR - https://www.scopus.com/pages/publications/33751313260
U2 - 10.1007/s10096-006-0210-3
DO - 10.1007/s10096-006-0210-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 17043835
AN - SCOPUS:33751313260
SN - 0934-9723
VL - 25
SP - 719
EP - 722
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
IS - 11
ER -